You are here

  • Home
  • Archive
  • Volume 11, Issue 12
  • First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial

 

Online download statistics by month:

Online download statistics by month: December 2023 to July 2025

AbstractFullPdf
Dec 2023909914404
Jan 2024366367149
Feb 202415716288
Mar 2024157158124
Apr 202412612889
May 202410310384
Jun 202410310482
Jul 2024949565
Aug 2024797954
Sep 202412512569
Oct 202412712777
Nov 202418318497
Dec 202415315974
Jan 202510410559
Feb 2025148148101
Mar 202510810965
Apr 202511011161
May 2025797944
Jun 2025474932
Jul 2025110
Total327933071818